Industry 5.0 in Trauma and Orthopaedics – Human–Machine Collaboration and Future Technologies

Industry 5.0 represents the next stage in the interaction between humans and advanced digital technologies. Rather than focusing purely on automation, Industry 5.0 emphasises human-centred technology, personalisation, sustainability and resilience.

In Trauma and Orthopaedics, this concept involves combining the clinical judgement and technical expertise of the orthopaedic surgeon with technologies such as artificial intelligence, robotics, additive manufacturing, smart sensors, extended reality and interconnected digital systems.

Industry 5.0 is not about replacing the orthopaedic surgeon – it is about combining human judgement with machine precision, computation and personalisation.

1. Human-Centricity

Technology should augment human capability rather than simply remove humans from the system. In orthopaedics, the surgeon retains responsibility for clinical reasoning and decision-making while digital technologies provide information, prediction, planning and precision.

2. Sustainability

Healthcare technology should increasingly consider resource utilisation, waste reduction, efficient manufacturing and environmental impact.

3. Resilience

Healthcare systems should remain functional during disruptions by using robust digital infrastructure, distributed manufacturing, telemedicine and adaptable supply chains.

• Artificial intelligence and machine learning.
• Deep learning and computer vision.
• Robotic-assisted surgery.
• Computer navigation.
• Additive manufacturing and 3D printing.
• Patient-specific implants and instruments.
• Smart implants and embedded sensors.
• Internet of Things and connected medical devices.
• Wearable sensors.
• Virtual reality.
• Augmented and mixed reality.
• Digital twins and computational simulation.
• Cloud-based healthcare systems.
• Telemedicine and remote rehabilitation.

Artificial intelligence allows computer systems to analyse large quantities of clinical, imaging and biomechanical information and identify patterns that may support clinical decisions.

Machine learning and deep learning represent important subsets of modern AI and are increasingly investigated across orthopaedic imaging, prediction and clinical decision support.

Potential Applications

• Fracture detection on radiographs.
• Fracture classification.
• Detection of osteoarthritis.
• Identification of implant loosening or failure.
• Preoperative planning.
• Risk stratification.
• Prediction of postoperative complications.
• Prediction of length of hospital stay.
• Analysis of patient-reported outcomes.
• Clinical decision-support systems.

AI should generally be considered a decision-support technology rather than an autonomous replacement for clinical judgement.

Deep-learning systems, particularly convolutional neural networks and newer computer-vision architectures, can analyse radiographs, CT and MRI images.

Potential uses include:

• Fracture detection.
• Automated measurements.
• Bone segmentation.
• Implant identification.
• Assessment of alignment.
• Osteoarthritis grading.
• Detection of periprosthetic abnormalities.

Performance may vary across patient populations, imaging equipment and institutions, making external validation essential before clinical deployment.

Trauma represents a particularly attractive area for AI because rapid interpretation of imaging and clinical information is frequently required.

Possible capabilities include:

• Automated fracture detection.
• Prioritisation of abnormal radiographs for review.
• Fracture classification assistance.
• Prediction of instability or displacement.
• Identification of patients at high risk of complications.
• Preoperative templating.
• Prediction of functional outcome.

Such systems may eventually function as an additional digital layer supporting the emergency physician, radiologist and orthopaedic surgeon.

Robotic-assisted surgery is one of the clearest examples of human-machine collaboration in modern orthopaedics.

The surgeon determines the clinical objective and supervises the procedure, while the robotic platform may improve execution of a predefined surgical plan.

Robotic systems may provide:

• High-precision bone preparation.
• Controlled implant positioning.
• Real-time navigation.
• Haptic boundaries in selected systems.
• Intraoperative data collection.
• Patient-specific surgical planning.

Orthopaedic robotic systems may be broadly described according to the degree of control given to the machine.

• Total knee arthroplasty.
• Unicompartmental knee arthroplasty.
• Total hip arthroplasty.
• Spinal instrumentation.
• Selected pelvic and acetabular procedures.
• Selected trauma applications.
• Potential future fracture reduction and fixation assistance.

Robotic systems have demonstrated improvements in several measures of technical accuracy, but superior technical precision should not automatically be assumed to produce superior long-term patient outcomes.

Precision is a surrogate outcome unless it translates into meaningful clinical benefit.

Additive manufacturing creates three-dimensional objects layer by layer from a digital model. In orthopaedics, CT-based anatomical data can be converted into three-dimensional models for planning, education and manufacturing.

Orthopaedic Applications

• Anatomical bone models.
• Preoperative planning.
• Patient-specific cutting guides.
• Patient-specific drilling guides.
• Custom implants.
• Porous implants designed for osseointegration.
• Custom tumour reconstruction.
• Complex revision arthroplasty.
• Reconstruction of major bone defects.

Three-dimensional models can be particularly useful when fracture anatomy is difficult to appreciate from conventional two-dimensional imaging.

Potential applications include:

• Complex acetabular fractures.
• Pelvic ring injuries.
• Complex periarticular fractures.
• Malunion correction.
• Nonunion reconstruction.
• Pre-contouring or selection of implants.
• Planning osteotomy planes.
• Patient-specific guides.

A physical or virtual 3D model may allow the surgeon to understand fragment geometry, simulate reduction and plan fixation before entering the operating theatre.

Conventional orthopaedic implants are manufactured in predetermined sizes and shapes. Industry 5.0 technologies create the possibility of designing implants according to an individual patient's anatomy and reconstructive requirements.

Potential indications include:

• Large bone defects.
• Complex pelvic reconstruction.
• Orthopaedic oncology.
• Revision arthroplasty.
• Complex deformity correction.
• Unusual anatomy where standard implants are unsuitable.

Porous structures may also be incorporated into selected custom implants to promote biological fixation and osseointegration.

A smart orthopaedic implant incorporates sensors or associated electronic technology capable of measuring information related to the implant, surrounding tissues or patient activity.

Potential measurements include:

• Load across the implant.
• Strain.
• Movement or micromotion.
• Temperature.
• Patient activity.
• Implant performance.
• Selected biochemical or physiological parameters in future sensor systems.

The long-term vision is to move orthopaedic implants from passive mechanical devices toward components of an interconnected monitoring system.

Conventional assessment of fracture healing relies on clinical examination and imaging. Sensor-enabled fixation devices may eventually provide additional objective information about mechanical changes occurring during fracture healing.

Future smart fixation systems could potentially help identify:

• Changes in load sharing during healing.
• Unexpected implant loading.
• Persistent instability.
• Patterns associated with delayed union or nonunion.
• Excessive activity during protected rehabilitation.

Many such applications remain developmental or investigational and require clinical validation.

The Internet of Things (IoT) refers to networks of connected devices capable of collecting and exchanging information.

In orthopaedics, connected systems may link:

• Wearable activity monitors.
• Smart implants.
• Rehabilitation devices.
• Hospital information systems.
• Patient mobile applications.
• Remote monitoring platforms.

This creates the possibility of extending orthopaedic monitoring beyond the hospital into the patient's daily environment.

Wearable sensors can provide continuous or repeated objective measurements of patient activity and movement.

Potential parameters include:

• Step count.
• Walking distance.
• Gait characteristics.
• Joint movement.
• Weight-bearing behaviour.
• Activity level.
• Rehabilitation compliance.

Such measurements may complement traditional clinic-based outcome scores and PROMs.

Digital rehabilitation platforms can allow patients to perform selected rehabilitation programmes at home while clinicians remotely monitor progress.

Potential components include:

• Video-guided exercises.
• Wearable motion sensors.
• Range-of-motion tracking.
• Activity monitoring.
• Pain and functional questionnaires.
• Automated reminders.
• Remote physiotherapist review.

Remote systems may be especially valuable when repeated hospital attendance is difficult, although they cannot replace physical assessment when clinical examination or imaging is required.

Virtual reality creates an immersive computer-generated environment in which users can interact with simulated anatomy or surgical scenarios.

Orthopaedic Applications

• Surgical training.
• Fracture fixation simulation.
• Arthroscopy training.
• Preoperative rehearsal.
• Anatomical education.
• Rehabilitation.
• Patient education.

Augmented reality overlays digital information onto the surgeon's view of the real world. Mixed reality allows greater interaction between virtual objects and the physical environment.

Potential orthopaedic applications include:

• Displaying three-dimensional anatomy during surgery.
• Visualising planned screw trajectories.
• Navigation during spinal instrumentation.
• Assistance with osteotomy positioning.
• Displaying tumour margins.
• Remote expert assistance.
• Surgical education.

Advanced three-dimensional visualisation can convert CT or MRI datasets into interactive spatial representations of anatomy.

For complex trauma, such systems may help surgeons understand fragment orientation, plan reduction, assess surgical approaches and communicate complex anatomy to trainees and patients.

A digital twin is a dynamic virtual representation of a physical object, system or patient that may be updated using real-world information.

In future orthopaedic practice, patient-specific digital models could potentially integrate:

• CT and MRI anatomy.
• Bone quality.
• Joint alignment.
• Gait information.
• Implant position.
• Biomechanical simulation.
• Wearable sensor data.
• Clinical outcomes.

This could allow simulation of different interventions before treatment, but comprehensive patient-level digital twins remain an emerging rather than routine orthopaedic technology.

Modern planning can combine three-dimensional imaging, AI, simulation and patient-specific anatomical modelling.

The surgeon may potentially simulate:

• Fracture reduction.
• Implant selection.
• Plate position.
• Screw trajectories.
• Osteotomy location and correction.
• Arthroplasty component size and position.
• Reconstruction of bone defects.

Industry 5.0 therefore shifts planning from choosing a standard solution toward designing a solution around the individual patient's anatomy and clinical problem.

During surgery, multiple digital technologies can potentially work together.

One of the defining principles of Industry 5.0 healthcare is that intelligent machines should function in collaboration with humans.

In orthopaedics:

• AI can analyse information.
• Software can generate a plan.
• Robotics can improve execution precision.
• Sensors can provide feedback.
• The surgeon interprets, modifies and supervises the process.

Machine intelligence provides computation; the surgeon provides clinical context, judgement, adaptability and responsibility.

Personalisation is one of the most important potential contributions of Industry 5.0 to orthopaedics.

Instead of treating every patient using identical implants, targets and rehabilitation protocols, future systems may increasingly incorporate:

• Individual anatomy.
• Bone quality.
• Age and comorbidities.
• Activity demands.
• Patient-specific biomechanics.
• Functional expectations.
• Patient-reported goals.

1. CT imaging generates a detailed three-dimensional model of the fracture.
2. AI assists with segmentation and fracture characterisation.
3. The surgeon virtually reduces the fracture.
4. Different fixation strategies are simulated.
5. A patient-specific model or guide is manufactured when useful.
6. Navigation or augmented reality assists intraoperative orientation.
7. The surgeon performs and supervises the definitive reduction and fixation.
8. Wearable or implant-based sensors monitor selected aspects of recovery.
9. Rehabilitation is adjusted using clinical assessment and objective functional data.

Not every component of this pathway is currently routine. It represents the direction toward which integrated Industry 5.0 orthopaedic systems may evolve.

Industry 5.0 technologies may also transform how orthopaedic surgeons are trained.

• Virtual reality surgical simulators.
• Haptic training systems.
• 3D-printed fracture models.
• Augmented-reality anatomy teaching.
• AI-assisted personalised learning.
• Objective analysis of technical performance.
• Remote mentoring and telementoring.

Simulation allows trainees to practise difficult procedures repeatedly without exposing patients to the early part of the learning curve.

Large clinical datasets can be combined with machine learning to study patterns that may be difficult to identify using traditional small datasets.

Potential applications include:

• Outcome prediction.
• Implant surveillance.
• Identification of risk factors.
• Registry analysis.
• Patient phenotyping.
• Personalised risk prediction.
• Detection of uncommon complications.

Industry 5.0 expands the technological discussion beyond speed and productivity to include sustainability.

Potential strategies include:

• Reducing manufacturing waste.
• Optimising instrument and implant supply chains.
• Local or distributed manufacturing where appropriate.
• Reducing unnecessary travel through remote follow-up.
• Improving operating theatre efficiency.
• Using data to reduce unnecessary investigations or interventions.

Resilience refers to the ability of healthcare systems to continue functioning and adapt during disruptions.

Relevant technologies may include:

• Cloud-based medical information systems.
• Telemedicine.
• Remote rehabilitation.
• Distributed manufacturing.
• Digital inventory management.
• AI-assisted workload prioritisation.

• Greater personalisation of treatment.
• Improved diagnostic support.
• Improved surgical planning.
• Greater technical precision.
• Patient-specific instruments and implants.
• Objective postoperative monitoring.
• Remote rehabilitation.
• Improved training and simulation.
• Potential improvement in workflow efficiency.
• Generation of large longitudinal datasets for research.

The presence of advanced technology does not automatically improve patient outcomes.

Important challenges include:

• High capital cost.
• Maintenance and infrastructure requirements.
• Learning curves.
• Limited access in resource-constrained healthcare systems.
• Interoperability between different platforms.
• Cybersecurity.
• Patient privacy.
• Data ownership.
• Algorithmic bias.
• Need for external validation.
• Regulatory challenges.
• Uncertain cost-effectiveness for some technologies.
• Lack of long-term outcome evidence for newer systems.

AI systems learn from the data used to develop them. If the training population is not representative, performance may differ when the system is applied to other populations.

Potential sources include:

• Under-representation of certain populations.
• Differences in imaging equipment.
• Differences in disease prevalence.
• Incorrect or inconsistent training labels.
• Historical biases contained within healthcare data.

AI systems therefore require appropriate external validation and ongoing monitoring after deployment.

Automation bias occurs when clinicians place excessive trust in recommendations generated by an automated system.

An AI recommendation can be incorrect because of poor input data, unusual anatomy, an inappropriate model or limitations in the algorithm.

The surgeon must remain capable of recognising when the technology is wrong.

Increased connectivity creates new vulnerabilities. Smart implants, cloud systems, wearable devices, robotic platforms and hospital networks may generate or exchange sensitive patient information.

Systems therefore require:

• Secure data storage.
• Encryption.
• Access control.
• Software updates.
• Network security.
• Clear governance of patient data.

Human-machine collaboration raises several important questions:

• Who is responsible when an AI recommendation is incorrect?
• Who owns data generated by a smart implant?
• How should informed consent address AI or robotic assistance?
• How transparent should algorithms be?
• How can unequal access to expensive technology be prevented?
• When should clinicians override an automated recommendation?

Technology should therefore augment rather than dilute professional accountability.

High-cost robotic systems and custom manufacturing may not be immediately accessible to every healthcare system.

However, Industry 5.0 does not necessarily mean that every hospital requires a surgical robot. Lower-cost technologies may have substantial impact, including:

• AI-assisted radiograph triage.
• Telemedicine.
• Low-cost wearable monitoring.
• Digital rehabilitation.
• Cloud-based clinical decision support.
• Regional 3D-printing hubs.
• Remote specialist consultation.

The most useful technology is therefore not necessarily the most sophisticated technology, but the technology that solves an important clinical problem safely and cost-effectively.

The most important future development may not be any single technology, but the integration of multiple technologies into one continuous patient-specific pathway.

Future systems may combine:

• AI-assisted diagnosis.
• Automated 3D reconstruction.
• Virtual surgical simulation.
• Patient-specific implants.
• Robotic or navigation-assisted execution.
• Smart implant monitoring.
• Wearable rehabilitation data.
• Continuous outcome analysis.

Data generated after treatment could then potentially inform subsequent planning systems, creating a continuous cycle of measurement, learning and personalised care.

• Industry 5.0 builds on the digital and automation technologies associated with Industry 4.0.
• Industry 5.0 emphasises human-centricity, sustainability and resilience.
• Human-machine collaboration is a central concept of Industry 5.0.
• AI can support fracture detection, classification, prediction and clinical decision-making.
• Robotic-assisted surgery combines machine precision with surgeon supervision and judgement.
• Additive manufacturing allows production of 3D models, patient-specific guides and custom implants.
• Smart implants incorporate sensors capable of generating information about the implant or its environment.
• IoT connects sensors, implants, wearables and digital healthcare systems.
• VR creates an immersive digital environment, whereas AR overlays digital information onto the real world.
• Digital twins are dynamic virtual representations of physical systems or patients and remain an emerging field in orthopaedics.
• Patient-specific implants are particularly useful in selected complex reconstructions, revision surgery and orthopaedic oncology.
• Wearable technology can provide objective information about activity, gait and rehabilitation.
• Technical precision does not automatically equal superior clinical outcome.
• Important challenges include cost, cybersecurity, algorithmic bias, data privacy, validation and unequal access.
• The surgeon remains the human decision-maker within the Industry 5.0 model.

1. Think beyond automation: Industry 5.0 centres on collaboration between humans and intelligent technology.
2. Personalise treatment: imaging, AI, simulation and additive manufacturing can increasingly tailor treatment to individual anatomy and clinical requirements.
3. Use AI as decision support: algorithms can assist interpretation and prediction, but clinical judgement remains essential.
4. Use machines for precision: robotics and navigation can improve the accuracy with which selected surgical plans are executed.
5. Connect treatment with recovery: smart implants and wearables may extend monitoring beyond the operating theatre.
6. Distinguish established technology from future concepts: not every proposed Industry 5.0 application has proven clinical benefit.
7. Demand evidence: new technology should demonstrate safety, meaningful patient benefit and cost-effectiveness rather than simply improved technical metrics.
8. Keep the surgeon in the loop: technology should augment human expertise rather than replace professional judgement and responsibility.

The future of Trauma and Orthopaedics is likely to involve a partnership between the surgeon, the patient and intelligent technology – combining human judgement with AI-driven insight, robotic precision, patient-specific manufacturing and continuous digital monitoring.